On June 27, the U.S. Food and Drug Administration (FDA) issued an urgent public safety alert after receiving multiple reports of illnesses related to Diamond Shruumz Brand Microdosing Chocolate Bars, Infused Cones and Micro and Macro Dose Gummies.

The firm, Prophet Premium Blends, initiated a voluntary nationwide recall of all products, but the FDA issued another warning yesterday saying that as of July 16, it became aware recalled Diamond Shruumz-brand products were still available for sale at locations across the country. All Diamond Shruumz-brand products have been recalled and should no longer be available for sale. Consumers should not purchase any Diamond Shruumz-brand products.

According to the firm, these products contain muscimol, a chemical found in some mushrooms, which could be a potential cause of symptoms consistent with those observed in individuals who became ill after consuming these products. Reports indicated a variety of severe symptoms including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting. As of the initial recall in June, 39 illnesses had been reported across almost 20 states, 23 of which required hospitalization.

Diamond Shruumz-brand products can be purchased online and in person at a variety of retail locations nationwide including smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC). The FDA is urging all retailers to stop selling the products due to the recall.

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, continue to investigate. The two organizations encourage consumers and retailers to report adverse effects to FDA's MedWatch Safety Information and Adverse Event Reporting Program.